
Asset manager · Early stage
Alethea
Alethea is an SEC-registered investment adviser that runs public equity strategies and also makes early-stage venture investments in biotechnology and health technology.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Alethea right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Alethea joined, from press and the firm’s own posts.
Every round Alethea joined
Round sizes, Alethea’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Alethea
Events where Alethea’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Alethea is based in the United States. It also has offices in San Diego and Bellevue.
2 fund vehicles are on public registers (SEC adviser filings), including ALETHEA FULCRUM FUND, LP and ALETHEA MEDTECH FUND, LP.
Stages: Early stage. Sectors: Biotech, Health tech. From the firm’s own website.
Alethea holds that outperformance requires an unconventional approach. In venture, it backs early-stage companies in biotech and health tech, led by independent-minded founders whose ideas could improve the lives of millions of people. From the firm’s own website.
Know before Alethea’s next round is announced.
PRO tracks Alethea’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.